Tag | Content |
---|
EnhancerAtlas ID | HS091-32424 |
Organism | Homo sapiens |
Tissue/cell | HepG2 |
Coordinate | chr22:18224600-18226200 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
CTCF | MA0139.1 | chr22:18225356-18225375 | CAGCCACCAGAGGGCAGTG | + | 7.65 | NFYA | MA0060.3 | chr22:18226109-18226120 | AACCAATCAGA | + | 6.62 | NFYB | MA0502.1 | chr22:18226104-18226119 | AGACCAACCAATCAG | + | 6.45 | RREB1 | MA0073.1 | chr22:18225245-18225265 | CCCCACCCCCACCCCCACCC | + | 6.27 | RREB1 | MA0073.1 | chr22:18225246-18225266 | CCCACCCCCACCCCCACCCC | + | 6.27 | RREB1 | MA0073.1 | chr22:18225233-18225253 | CCTCCCCCCACCCCCCACCC | + | 6.45 | RREB1 | MA0073.1 | chr22:18225236-18225256 | CCCCCCACCCCCCACCCCCA | + | 6.69 | RREB1 | MA0073.1 | chr22:18225240-18225260 | CCACCCCCCACCCCCACCCC | + | 7.47 |
|
| Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
SE_09461 | chr22:18223512-18227741 | CD14 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 2 | Chromosome | Start | End |
chr22 | 18224812 | 18225629 | chr22 | 18225683 | 18225762 |
|
| Number: 1 | ID | Chromosome | Start | End |
GH22I017741 | chr22 | 18224761 | 18225573 |
|
Enhancer Sequence | AGTTTCCAAG GAACCAAACA TACCCAACCC CCAAGGCCCA GCTCAATTGG AGCTGCAGCC 60 CCAAAGTTTT CCTGATTCCC TGCAGAGCAG AGCACCCAGC TCCTCCAGCA CCTCATCACT 120 CCCCCAGCAC CGAATCTGTG CCTCGCTCGT TCCCGAAGCT TATCCACCTT GCTTCAGTTA 180 CGGACACGTC CTCTCTCCCT CTGGCCACCA GCCGAGTAGC AACAGGAATC TTTCCTGATC 240 CGTCTGTGTC CAGCCGAGTG AACGGACTCA CCAAAGAAAC CCCGGCAGCC AGAGCCTCTA 300 CCTTGCCCCT CTTTCCAGGC TCGCCAGGGA CTAGATTCAC AGTCCCTGTC ACCTGCAGGC 360 TAAGTGAACT GCCATGATCA CTTTTGCAGG TGCCACTTGA GTCAACCCCG GTTTCTCAGT 420 CTAGAGGCAA AGGCCGGCAT GGAGAAGAGC GAGAGAAAAA CACCAGGGCA GACTGGGGCT 480 ACAGTCACCC CCACAGCAGT GCTGACAGCA GAGCTGTGCC TGTCCACTCC TGCCCTTCCT 540 GGACCTTCCC AAAGGGATCT GGGGTTTCTC CTCAGTTCAG GGCGAGCCAG AAGATATGCT 600 GGCTGGATTA GAAGGCAGAG ACATTCTCAG ACACCTCCCC CCACCCCCCA CCCCCACCCC 660 CACCCCGGTC TAGTGGGGAA CTCCAGCCAC GTCCTCAAGC ACCTGATCTA AGACAGGCGG 720 GAGGCAGAAG GCTGGGTCAG CTGTTGGTCT CCCCCACAGC CACCAGAGGG CAGTGCAACC 780 CTTGAGCTTG GAAGGCCTGG ACCAGGGTCC GGGGATCCCT GCAGGCTTTC AGGGCAGGGA 840 TTCTACCTGC GTCAGAATCC TCTGGGCAGT CTCCCGCCCT AAAACAGCCT GATGCAGGCA 900 GCTGGAGTAG GGCCCAAGGC CTGCATTTGG AAAAGGTTTC TCGTGTAATT CCAATGTGCA 960 CACTACTGAA AGCCAGCGTC GCAGGGCTGG ATCTGGAAGT GGGTGAGCCT CCACTCGCCC 1020 CCAGCCTCCA CTCGGGACAG CCCCTGTCCA TAGAAGCAGC CCCTTGGCAA AGGGGAGTGG 1080 AGCTGGAGGC TGGAGGAGAG TGCAGGGATC AGCAACAGGA AAGGTGAACA GTCTGGAAAC 1140 CATGGTGACC TGGAGTCAGT GCCCTACAGT GGGAGGGCGG CTGAGGCCCA CCTCAAGAAG 1200 GGGCCTGGCC CCATGTCCCA GTGGTAACAT GGCCACAAGC TGTGTGATCT GGAGCTAGTC 1260 ATTTACCCTT TGCTGGACCT GGGTTTCCTC ACCTGGAAAT GAGGTTCCAA ATACTTCTGT 1320 GTTCTTGTAT AGGTAATCAC GGAGCATAAT GTATGAAAGG AAATATGTCA GGTATAGACA 1380 GTGCAAAAGT CACTGTGAAA CCAGTGGGCC TCAATCAATG GGACAGTCAG CCAGGCCTGC 1440 TTGGGGAGGC AGGGGCCGCA CCGGTAGTGC CACCTGGGGG CTTTGCCCAG ACCCAGCAAT 1500 GCCCAGACCA ACCAATCAGA ATCTCTGGAG GTGAGATGCA GGCACCAGCA TTTAAAGCTC 1560 CAGGTCCTTG AAATGATACA AGGCCAAGTG TGAGAACCCC 1600
|